Clinical Trials
344
Active:10
Completed:151
Trial Phases
5 Phases
Phase 1:14
Phase 2:27
Phase 3:31
+2 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (230 trials with phase data)• Click on a phase to view related trials
Not Applicable
123 (53.5%)Phase 4
35 (15.2%)Phase 3
31 (13.5%)Phase 2
27 (11.7%)Phase 1
14 (6.1%)Wearables and Artificial Intelligence in Advanced Heart Failure Care
Not yet recruiting
- Conditions
- Advanced Heart Failure
- First Posted Date
- 2025-07-04
- Last Posted Date
- 2025-07-04
- Lead Sponsor
- UMC Utrecht
- Target Recruit Count
- 200
- Registration Number
- NCT07051356
- Locations
- 🇳🇱
UMC Utrecht, Utrecht, Netherlands
Course of Face-to-face Interactions in Adults With Autism
Not Applicable
Recruiting
- Conditions
- Autism Spectrum Disorder (ASD)Neurotypical
- First Posted Date
- 2025-04-13
- Last Posted Date
- 2025-04-13
- Lead Sponsor
- UMC Utrecht
- Target Recruit Count
- 54
- Registration Number
- NCT06925308
- Locations
- 🇳🇱
Dimence Groep, Deventer, Overijssel, Netherlands
Developing an Intervention Facilitating the Use of Eye Contact in Adults With Autism
Recruiting
- Conditions
- Autism Spectrum Disorder (ASD)Relative (Related Person)Care Giver
- First Posted Date
- 2025-04-11
- Last Posted Date
- 2025-04-11
- Lead Sponsor
- UMC Utrecht
- Target Recruit Count
- 18
- Registration Number
- NCT06924008
- Locations
- 🇳🇱
Dimence Groep, Deventer, Overijssel, Netherlands
Autistic Eye Contact?
Completed
- Conditions
- Autism Spectrum Disorder (ASD)Neurotypical
- First Posted Date
- 2025-04-10
- Last Posted Date
- 2025-04-10
- Lead Sponsor
- UMC Utrecht
- Target Recruit Count
- 30
- Registration Number
- NCT06921876
- Locations
- 🇳🇱
Dimence Groep, Deventer, Overijssel, Netherlands
Coronary Sinus Reducer in Coronary Microvascular Disease
Not Applicable
Not yet recruiting
- Conditions
- Angina (Stable)Coronary Microvascular Disease
- First Posted Date
- 2025-03-27
- Last Posted Date
- 2025-03-27
- Lead Sponsor
- UMC Utrecht
- Target Recruit Count
- 50
- Registration Number
- NCT06898541
- Prev
- 1
- 2
- 3
- 4
- 5
- 69
- Next
News
Portable Gene Therapy Device Could Revolutionize On-Demand Personalized Medicine for Rare Diseases
The NANOSPRESSO device enables hospital pharmacists to create personalized nanomedicines on-demand using portable cartridges containing genetic material and lipid components.
Study Finds No Short-Term Benefit of Adding Revascularization to Medical Therapy for Carotid Stenosis
A multicenter randomized trial reveals no advantage in adding revascularization to optimized medical therapy for patients with carotid stenosis in the first two years of treatment.